BMA BMA
Company Profile ↓Company Overview
BMA (BMA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 45.6% per year over the last five years.
Revenue has grown at a 74.1% CAGR over the past five years.
Trades at an undemanding P/E of 0.0.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -26.4%, earnings -74.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 74.1%, profit CAGR 45.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 74.10% |
| 1 Year: | -26.37% |
Compounded Profit Growth
| 5 Years: | 45.59% |
| 1 Year: | -74.32% |
Stock Price Performance
| 1 Year: | +34.11% |
| 6 Months: | -6.12% |
| 3 Months: | +31.18% |
| 1 Month: | -2.27% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)47.06 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 74.1% over 5 years.
- Profit CAGR of 45.6% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.07T | 1.02T | 870.50B | 1.50T | 1.40T |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Interest Expense | 412.93B | 383.12B | 392.37B | 547.15B | - | 502.59B |
| Pretax Income | 168.22B | 106.29B | 245.32B | -38.03B | - | 212.69B |
| Tax Provision | 37.44B | 45.69B | 95.78B | -4.96B | - | 72.93B |
| Net Income | 130.52B | 59.47B | 149.14B | -33.10B | - | 140.24B |
| Diluted EPS | - | 930.13 | 2,332.40 | -517.61 | - | 2,193.32 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.13T | 3.28T | 8.08T | 5.95T | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | 574.16B | 2.09T | 4.67T | 2.56T | - |
| Pretax Income | 145.94B | 401.07B | 2.48T | 473.59B | - |
| Tax Provision | 7.19B | 124.57B | 808.75B | 44.10B | - |
| Net Income | 138.74B | 276.45B | 1.67T | 428.19B | - |
| Diluted EPS | - | 673.09 | 9,185.05 | 5,069.38 | 4,527.53 |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|
| Operating Cash Flow | 271.77B | 3.51T | -244.15B | 2.63T |
| Investing Cash Flow | -42.03B | -164.99B | 232.96B | -175.87B |
| Financing Cash Flow | -52.64B | -169.39B | -163.06M | -778.80B |
| Capital Expenditure | -41.81B | -164.97B | -163.49B | -163.80B |
| Free Cash Flow | 229.96B | 3.35T | -407.65B | 2.47T |
| Net Change in Cash | 177.10B | 3.18T | -11.35B | 1.68T |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | 12.3% | 8.4% | 20.6% | 7.2% | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BMA
Should Value Investors Buy Macro Bank (BMA) Stock? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQWUtSRGUwTjNBelptZmRSaHl5ZVlEOUxaekNVSFhHTWlxQUJsMlNRaEtkQmZ0akZPdHI0TFRxM2NOeXFfUk8wbi04Mm5semVGNERER0lZTTU0SlFTVHJINUVfQ1JWMGVIU3lSQi1pZGJpdS1lMGYxcFhTdFVub2tYOXRoYU5fWkRoM1pla1…
Macro Bank Inc. (NYSE:BMA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPcW9mM3A1T3Q1SlZWWnJuR3dBZ09GQ2VQWU43SWRKNzAyMV9GUWJJMDdPaEswWWoyLXU5dHJkR3UyVVg4VjlmVEVRRlZSSmlzb3FyWi1LaktKd1FuR2dqWEVCQ2o5aE5xOUQ5T3NMb2VaTmQ1dXBXWTdCdk9YLXNsN20waHNOTXBJNUlzQX…
Banco Macro SA (BMA) Stock Down 6.2% but Still Overvalued -- GF Score: 67/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPYmUxYmR5eE1JRWdxbTdIZ0czaW00blFqQl85Njc2bkVHUEJ5TkU1WWwzUjJDcENYTVFBUUY5UkJPaFUwMmo3dHFRRjM1NkZ4UVFGa3o5SFloOXhqU3l0RFRZa0thZHRfSHJJbUZqR0MxZ0paenFTNHVPUF9EcGNRN3N3TG9pTDFpWTlkM2…
Are You Looking for a Top Momentum Pick? Why Banco Macro (BMA) is a Great Choice - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQR3BXS3Eya21FeDZSYVFFRWFVQnFPMkNPWnk3cGoxbmNIUkh4WGdKb09lNVBJVmVjaXhBVU1UM0J1eG9HYnlwV19YYUU0SUhfOTV1cEF6WE1kNjdOQXh6bGlZZUg4RFAwRHp2RzNyWTNhVk5HLXE4OThudE5iak5FYVp6Yy0wSjZtcVV4dn…
(BMA) Volatility Zones as Tactical Triggers - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNZG9LMERQZXhnVWJXVHJNMEVLT2J2M1FvZGI5akVlNDlKTnNfOHJKbmc5UWxxT2tHdDBPMFliaHFWZHNtZi16cW1Ic0x6VWd0Vk9XeFBIb29GVVBDNUFncG1FbGpPa3JuVUhxZlVuM0tYSnFyTlJXckgtemVnWjJycG9RNVlhNTk4dEpEek…
Monthly Dividend Stock In Focus: Banco Macro - Sure Dividend
<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB1bHJEYzV5Uy1LUms0ZXFFSWRVNnFvSWIwUmdtWW9kRGhsaVg1YmxwUlhOVGV6SDdRYlVXNWtpRWZaYXphRjRzQ2U0bE1LNDVJdEczZUZlV183U2Y1UnliSjg5RmdPT1U?oc=5" target="_blank">Monthly Dividend Stock In Fo…
BMA — Frequently Asked Questions
What is the current share price of BMA?
As of 2026-08-05 17:25 PDT, BMA trades at $89.57 on NASDAQ/NYSE. Its 52-week range is $37.79 to $101.13.
What is the P/E ratio of BMA?
BMA trades at a trailing price-to-earnings (P/E) ratio of 0.02.
Is BMA a good stock to buy?
This page provides a data-driven analysis of BMA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.